Home > Insider Trading > Filing (0001104659-24-132188)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1671502	Quoin Pharmaceuticals Ltd.	QNRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1959547	Michael Myers	C/O Quoin Pharmaceuticals Ltd., 42127 Pleasant Forest Court Ashburn VA 20148	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2024-12-23	555,556	$0.45	602,808	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ads	Series F Warrants (right to buy)	Acquisiton	2024-12-23	555,556	$0.00	555,556	$0.45
Ads	Series G Warrants (right to buy)	Acquisiton	2024-12-23	555,556	$0.00	555,556	$0.45

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
555,556	2024-12-23	2026-12-23	No	4	P	Direct
555,556	2024-12-23	2029-12-24	No	4	P	Direct

Footnotes

Reported securities are represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary share of the Issuer.
Each ADS purchased together with a Series F Warrant to purchase one ADS and a Series G Warrant to purchase one ADS in the Issuer's public offering which closed on December 23, 2024, at a combined public offering price of $0.45. The Series F Warrants and the Series G Warrants are collectively referred to as the "Warrants."
The Warrants were exercisable immediately, subject to a beneficial ownership cap.